Form D Explorer

Form D — Kriya Therapeutics, Inc.

0001811209-25-000002 · filed 2025-08-15

Offering

Industry
Biotechnology
Exemptions
06b
Total offering
$313,297,440
Total sold
$313,297,440
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Kriya Therapeutics, Inc.
CIK
1811209
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
4105 HOPSON ROAD
MORRISVILLE, NC 27560
Phone
(833) 574-9289

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View original on SEC EDGAR.